Calliditas Therapeutics AB (CALT)
19.57
-0.37
(-1.86%)
USD |
NASDAQ |
May 02, 14:59
Calliditas Therapeutics Price: 19.57 for May 2, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 01, 2024 | 19.94 | 19.94 | 19.94 | 19.94 | 0.000 |
Apr 30, 2024 | 19.86 | 19.97 | 19.41 | 19.94 | 4762.00 |
Apr 29, 2024 | 19.14 | 19.55 | 17.68 | 18.65 | 2768.00 |
Apr 26, 2024 | 19.44 | 20.15 | 18.48 | 19.50 | 3791.00 |
Apr 25, 2024 | 18.80 | 20.38 | 18.66 | 19.45 | 5994.00 |
Apr 24, 2024 | 18.83 | 18.83 | 18.50 | 18.50 | 1459.00 |
Apr 23, 2024 | 17.50 | 19.19 | 17.50 | 18.20 | 1891.00 |
Apr 22, 2024 | 18.25 | 19.30 | 17.50 | 18.08 | 2943.00 |
Apr 19, 2024 | 18.94 | 19.70 | 17.68 | 18.70 | 4017.00 |
Apr 18, 2024 | 18.17 | 18.82 | 17.61 | 17.65 | 6178.00 |
Apr 17, 2024 | 18.43 | 18.88 | 17.60 | 18.74 | 6770.00 |
Apr 16, 2024 | 18.44 | 18.60 | 16.00 | 17.80 | 9408.00 |
Apr 15, 2024 | 18.64 | 18.95 | 18.00 | 18.95 | 1251.00 |
Apr 12, 2024 | 19.24 | 19.80 | 19.00 | 19.00 | 11737.00 |
Apr 11, 2024 | 20.79 | 21.06 | 20.13 | 20.53 | 18523.00 |
Apr 10, 2024 | 20.97 | 21.91 | 20.64 | 21.52 | 7657.00 |
Apr 09, 2024 | 23.00 | 23.00 | 20.70 | 22.50 | 2728.00 |
Apr 08, 2024 | 21.40 | 22.68 | 21.40 | 21.51 | 7072.00 |
Apr 05, 2024 | 21.03 | 21.63 | 21.03 | 21.63 | 7297.00 |
Apr 04, 2024 | 22.00 | 22.51 | 21.93 | 22.08 | 6272.00 |
Apr 03, 2024 | 21.25 | 21.25 | 21.25 | 21.25 | 0.000 |
Apr 02, 2024 | 21.00 | 21.25 | 20.86 | 21.25 | 4719.00 |
Apr 01, 2024 | 21.43 | 21.96 | 21.00 | 21.00 | 5579.00 |
Mar 28, 2024 | 21.01 | 21.01 | 21.01 | 21.01 | 1163.00 |
Mar 27, 2024 | 21.77 | 21.77 | 21.26 | 21.49 | 3966.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
11.50
Minimum
Oct 20 2022
36.65
Maximum
Nov 30 2020
21.92
Average
21.00
Median
Price Benchmarks
DBV Technologies SA | 0.6651 |
Cellectis SA | 2.93 |
Adaptimmune Therapeutics PLC | 1.20 |
Akari Therapeutics PLC | 1.63 |
Biodexa Pharmaceuticals Plc | 1.27 |
Price Related Metrics
PS Ratio | 3.864 |
Price to Book Value | 15.79 |
Earnings Yield | -5.02% |
Market Cap | 525.18M |